Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Grimm

Showing results (11-20 of 154) with videos related to

Pageof 16
Sort By:
Gene Therapy|March 18, 2025
AAV vector engineering for human aorta transduction: becoming a smooth operatorKleopatra Rapti, Dirk Grimm
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 22, 2015
E Pluribus Unum: 50 Years of Research, Millions of Viruses, and One Goal--Tailored Acceleration of AAV EvolutionDirk Grimm, Sergei Zolotukhin
Virus Genes|August 2, 2017
Next-generation AAV vectors for clinical use: an ever-accelerating raceJonas Weinmann, Dirk Grimm
Human Gene Therapy|August 25, 2017
Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and EvolutionDirk Grimm, Hildegard Büning
Human Molecular Genetics|July 2, 2019
Next-generation AAV vectors-do not judge a virus (only) by its coverClaire Domenger, Dirk Grimm
Biotechnology Journal|February 10, 2015
CRISPR genome engineering and viral gene delivery: a case of mutual attractionFlorian Schmidt, Dirk Grimm
Nature Biomedical Engineering|February 13, 2021
'Hit and run' therapy averts macular degenerationFelix Bubeck, Dirk Grimm
Molecular Therapy. Methods & Clinical Development|May 22, 2023
Every little bit helps: A single-residue switch in a vascular AAV enables blood-brain barrier penetrationDirk Grimm, Mathieu Nonnenmacher
Signal Transduction and Targeted Therapy|May 26, 2021
Membrane-destabilizing ionizable phospholipids: Novel components for organ-selective mRNA delivery and CRISPR-Cas gene editingNing Meng, Dirk Grimm
Journal of Molecular Biology|May 22, 2018
High-Throughput Dissection of AAV-Host Interactions: The Fast and the CuriousAnne-Kathrin Herrmann, Dirk Grimm
Pageof 16

Showing results (11-20 of 154) with videos related to

Sort By:
Pageof 16
Gene Therapy|March 18, 2025
AAV vector engineering for human aorta transduction: becoming a smooth operatorKleopatra Rapti, Dirk Grimm
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 22, 2015
E Pluribus Unum: 50 Years of Research, Millions of Viruses, and One Goal--Tailored Acceleration of AAV EvolutionDirk Grimm, Sergei Zolotukhin
Virus Genes|August 2, 2017
Next-generation AAV vectors for clinical use: an ever-accelerating raceJonas Weinmann, Dirk Grimm
Human Gene Therapy|August 25, 2017
Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and EvolutionDirk Grimm, Hildegard Büning
Human Molecular Genetics|July 2, 2019
Next-generation AAV vectors-do not judge a virus (only) by its coverClaire Domenger, Dirk Grimm
Biotechnology Journal|February 10, 2015
CRISPR genome engineering and viral gene delivery: a case of mutual attractionFlorian Schmidt, Dirk Grimm
Nature Biomedical Engineering|February 13, 2021
'Hit and run' therapy averts macular degenerationFelix Bubeck, Dirk Grimm
Molecular Therapy. Methods & Clinical Development|May 22, 2023
Every little bit helps: A single-residue switch in a vascular AAV enables blood-brain barrier penetrationDirk Grimm, Mathieu Nonnenmacher
Signal Transduction and Targeted Therapy|May 26, 2021
Membrane-destabilizing ionizable phospholipids: Novel components for organ-selective mRNA delivery and CRISPR-Cas gene editingNing Meng, Dirk Grimm
Journal of Molecular Biology|May 22, 2018
High-Throughput Dissection of AAV-Host Interactions: The Fast and the CuriousAnne-Kathrin Herrmann, Dirk Grimm
Pageof 16